Atlas Trials

Placebo- Controlled Study to Evaluate the Safety and Immunogenicity of the RSV-F Vaccine in Elderly Adults

Clinical trial NCT02266628 · COMPLETED

Trial details

NCT number
NCT02266628
Sponsor
Novavax
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Respiratory Syncytial Virus (RSV)
Start date
2014-10-01
Primary completion
2016-03-01
Enrollment
1599

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.